Monocyte-derived macrophages play a central role in the pathogenesis of atherosclerosis. They actively promote oxidation of LDL, express scavenger receptors, and secrete cytokines and growth factors which influence the migration, growth and function of arterial cells. They may also contribute to plaque instability b secretion of metalloproteinases. Our laboratory characterized transcriptional control elements of the scavenger receptor A (SR-A) gene that are required for macrophage-specific expression of this gene. We also demonstrated that regulatory elements of the SR-A gene can be used to specifically target reporter reporter gene expression in macrophage foam cells of murine atherosclerotic lesions. A major aim of this unit is to fully develop and validate a variety of vector systems for the overexpression or disruption of genes in a macrophage-specific manor. Vector based on the SR-A promoter and other macrophage-specific promoters will be developed to allow targeting of cDNAs to mature macrophages and macrophage progenitor cells. These vectors will also be used to direct expression of Cre-recombinase or a doxycycline-inducible transcriptional activator in transgenic mice. The ability of these vectors to direct efficient macrophage-specific expression of genes in forms cells of atherosclerotic lesions will be assessed in apo E- deficient, or LDL receptor-deficient (LDLR) mice, utilizing reporter genes, such as human growth hormone.
A second aim will be to utilize this information to determine the impact on atherogenesis of macrophage specific overexperssion of genes that could influence atherogenesis. Overexpression of 15-lipoxygenase will serve as an example of a gene that can enhance the oxidation of LDL, and overexpression of phospholipid-hydroperoxide glutathione peroxidase as an example of a gene that should decrease oxidation of LDL. In a similar manner we will determine the consequences to the integrity of the artery wall of macrophage-specific overexpression of metalloproteinases, including the 92 kDa gelatisase, interstitial collagenase, and stromelysin, expressed individually and in combination. The effects of overexpression of these genes on the atherosclerotic process will be tested in appropriate murine models. Finally, we will determine the consequences for atherogenesis of macrophage-specific disruption of the c-jun gene. C-jun appears to regulate transcription of several important macrophase genes, including SR-A, cytokines, and metalloproteinases. Because a global disruption of c-jun results in embryonic lethality, macrophage-specific disruption will serve as a paradigm for the evaluation of gene required for normal development but which may contribute to atherogenesis. The information gained from these studies should yield fundamental insights into the role that macrophages play in atherogenesis and could be used to develop novel and effective therapeutic strategies.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL056989-05
Application #
6450712
Study Section
Project Start
2001-04-01
Project End
2002-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
5
Fiscal Year
2001
Total Cost
$274,326
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Pechlaner, Raimund; Willeit, Peter; Summerer, Monika et al. (2015) Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with progressive atherosclerosis and incident cardiovascular disease. Arterioscler Thromb Vasc Biol 35:229-36
Huang, Wendy; Ghisletti, Serena; Saijo, Kaoru et al. (2011) Coronin 2A mediates actin-dependent de-repression of inflammatory response genes. Nature 470:414-8
Wan, Yihong; Evans, Ronald M (2010) Rosiglitazone activation of PPARgamma suppresses fractalkine signaling. J Mol Endocrinol 44:135-42
Chou, Meng-Yun; Fogelstrand, Linda; Hartvigsen, Karsten et al. (2009) Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest 119:1335-49
Bergmark, Claes; Dewan, Asheesh; Orsoni, Alexina et al. (2008) A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma. J Lipid Res 49:2230-9
Liguori, Antonio; D'Armiento, Francesco P; Palagiano, Antonio et al. (2008) Maternal C-reactive protein and developmental programming of atherosclerosis. Am J Obstet Gynecol 198:281.e1-5
Tsimikas, Sotirios; Aikawa, Masanori; Miller Jr, Francis J et al. (2007) Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression. Arterioscler Thromb Vasc Biol 27:175-81
Ricote, Mercedes; Glass, Christopher K (2007) PPARs and molecular mechanisms of transrepression. Biochim Biophys Acta 1771:926-35
Tsimikas, Sotirios; Brilakis, Emmanouil S; Lennon, Ryan J et al. (2007) Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events. J Lipid Res 48:425-33
Palinski, Wulf; Yamashita, Tomoya; Freigang, Stefan et al. (2007) Developmental programming: maternal hypercholesterolemia and immunity influence susceptibility to atherosclerosis. Nutr Rev 65:S182-7

Showing the most recent 10 out of 120 publications